Lupoid sclerosis.
Lupoid sclerosis (LS) is a controversial entity, comprising features of both systemic lupus erythematosus and multiple sclerosis. Diagnostic criteria are a matter of debate, as well as the role of antinuclear and antiphospholipid antibodies. In this review, clinical and laboratory findings of LS available on Pubmed up to date are discussed.
Keiserman
Briele
B
Department of Rheumatology, Sao Lucas Hospital, Pontifical Catholic University of Rio Grande do Sul, Av. Ipiranga 6690/220, Porto Alegre, Brazil. briele.K@gmail.com
da Silva
Luiz Fernando Garcias
LF
Keiserman
Mauro W
MW
von Mühlen
Carlos Alberto
CA
Staub
Henrique Luiz
HL
D000974:Antibodies, Antinuclear / Q000097:blood / Q000276:immunology*; D017152:Antibodies, Antiphospholipid / Q000097:blood / Q000276:immunology*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000276:immunology* / Q000473:pathology; D009103:Multiple Sclerosis / Q000150:complications / Q000276:immunology* / Q000473:pathology; D039781:PubMed
D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid